Birkett Bernard 4

4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 22, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-02-20+1,9696,889.42 total
  • Award

    Stock Options (Right to Buy)

    2024-02-20+8,3468,346 total
    Exercise: $350.18From: 2025-02-20Exp: 2034-02-20Stock Options (Right to Buy) (8,346 underlying)
Footnotes (2)
  • [F1]2021 PSUs (PP20) award vesting net of taxes withheld.
  • [F2]This grant vests in four equal installments beginning on February 20, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT